Tandem Diabetes Care TNDM Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tandem Diabetes Care's investment proceeds?
- Tandem Diabetes Care (TNDM) reported investment proceeds of $26.95M in Q1 2026.
- How has Tandem Diabetes Care's investment proceeds changed year-over-year?
- Tandem Diabetes Care's investment proceeds decreased by 58.6% year-over-year, from $65.07M to $26.95M.
- What is the long-term trend for Tandem Diabetes Care's investment proceeds?
- Over 4 years (2021 to 2025), Tandem Diabetes Care's investment proceeds has grown at a -18.1% compound annual growth rate (CAGR), from $570.02M to $257.07M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.